Submit the keyword or topic you are searching for

  1. Home
  2. Health
  3. Merck gains after latest survival data for Summit’s cancer drug
Health

Merck gains after latest survival data for Summit’s cancer drug

featured-image

Erik S. Lesser/Getty Images News Merck ( NYSE: MRK ) shares inched higher on Friday after Summit Therapeutics ( NASDAQ: SMMT ) announced the latest survival data related to its lung cancer therapy, ivonescimab, developed with Chinese biotech Akeso ( OTCPK:AKESF ). Citing an interim readout from a China-based Phase 3 trial called.

My Protein Germany

Myprotein UK

Menkind UK

Top News

What Region In America Tends To Have The Cheapest Gas Prices (And Is There A Reason Why?)

Gas prices can vary quite a bit from state to state, but one...

13 years on, high court allows Bolivians to fly back home

'Thunderbolts' tops global box office with $162 million haul; 'Hit 3' makes it into Top 10 list with $800K collection

Sports News | Ajinkya Rahane Surpasses Chris Gayle to Become 9th Highest IPL Run Getter

Related Posts

post-thumbnail
Health

Americans Still Struggling with Proper Handwashing Habits

post-thumbnail
Health

How to listen like a therapist with four ways to build deeper connection and trust

post-thumbnail
Health

Varicose veins increase your risk of dementia, study finds

post-thumbnail
Health

Tauranga McDonald’s worker tells customers to halve order and ‘ration it’

post-thumbnail
Health

Watch Tuesday's full episode of Fast Money — May 6, 2025

post-thumbnail
Health

Norwegian study shows teens who move more cut their depression risk

post-thumbnail
Health

Social media hurts teens with anxiety and depression more than healthy peers

post-thumbnail
Health

New AI model could ‘predict disease’ before it happens using NHS data